Toxicology of Nanomaterials

Biological Concepts and Techniques in Toxicology: An Integrated Approach

Volumn , Issue , 2006, Pages 217-233

  Monteiro Riviere, Nancy A ^a   Ryman Rasmussen, Jessica P ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33845739533     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (75)

1. Jortner J, Rao CNR. Nanostructured advanced materials. Perspectives and directions. Pure Appl Chem 2002; 74:1491-1506.
2. Zhan GD, Kuntz JD, Wan J, Mukherjee AK. Single-wall carbon nanotubes as attractive toughening agents in alumina-based nanocomposites. Nat Mater 2003; 2:38-42.
3. Oberdorster G, Oberdorster E, Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 2005. Http:// dx.doi.org/.
4. Colvin VL. The potential environmental impact of engineered nanomaterials. Nat Biotechnol 2003; 21:1166-1170.
5. Halford B. Nano dictionary. Chem Eng News 2005; 83:31.
6. Beckett WS, Chalupa DF, Pauly-Brown A, et al. Comparing inhaled ultrafine vs. Fine zinc oxide particles in healthy adults: a human inhalation study. Am J Respir Crit Care Med 2005 (published ahead of print).
7. NNI. What is nanotechnology? 2004. Http://www.nano.gov/html/facts/whatisnano.html.
8. Nichols G, Byard S, Bloxham MJ, et al. A review of the terms agglomerate and aggregate with a recommendation for nomenclature used in powder and particle characterization. J Pharm Sci 2002; 91:2103-2109.
9. United States Geological Survey. Mineral commodity summaries. 2005. Http://minerals.usgs.gov/minerals/pubs/commodity/titanium/tidiomcs05.pdf.
10. Driscoll KE, Maurer JK, Lindenschmidt RC, Romberger D, Rennard SI, Crosby L. Respiratory tract responses to dust: relationships between dust burden lung injury alveolar macrophages fibronectin release and the development of pulmonary fibrosis. Toxicol Appl Pharmacol 1990; 106:88-101.
11. Oberdorster G, Ferin J, Lehnert BE. Correlation between particle size in vivo particle persistence and lung injury. Environ Health Perspect 1994; 102(suppl 5):173-179.
12. Oberdorster G. Pulmonary effects of inhaled ultra-fine particles. Int Arch Occup Environ Health 2000; 74(1):1-8.
13. Zhang Q, Kusaka Y, Sato K. Differences in the extent of inflammation caused by intratracheal exposure to three ultrafine metals: role of free radicals. J Toxicol Environ Health 1998; 53:423-438.
14. Churg A, Gilks B, Dai J. Induction of fibrogenic mediators by fine and ultra-fine titanium dioxide in rat tracheal explants. Am J Physiol 1999; 277:975-982.
15. Drumm J, Buhl R, Kienast K. Additional NO2 exposure induces a decrease in cytokine specific mRNA expression and cytokine release of particle and fiber exposed human alveolar macrophages. Eur J Med Res 1999; 4(2):59-66.
16. Rahman Q, Narwood J, Hatch G. Evidence that exposure of particulate air pollutants to human and rat alveolar macrophages lead to different oxidative stress. Biochem Biophys Res Commun 1997; 240:669-672.
17. Donaldson K, Stone V. Current hypotheses on the mechanism of toxicity by ultrafine particles. Ann Super Sanita 2003; 39(3):405-410.
18. Rahman Q, Lohani M, Dopp E, et al. Evidence that ultrafine titanium dioxide induces micronuclei and apoptosis in Syrian hamster embryo fibroblasts. Envrion Health Per-spect 2002; 110(8):797-800.
19. Schulz J, Hohenberg H, Pflucker F, et al. Distribution of sunscreens on skin. Adv Drug Del Rev 2002; 54(suppl 1):S157-S163.
20. Tremblay JF. Fullerenes by the ton. Chem Eng News 2003; 81:13-14.
21. Kroto HW, Heath JR, O’Brien SC, Curl RF, Smalley RE. C60: buckminsterfullerene. Nature 1985; 318:162-163.
22. Yamago S, Tokuyama H, Nakamura E, et al. In-vivo biological behavior of a water-miscible fullerene-C-14 labeling absorption distribution excretion and acute toxicity. Chem Biol 1995; 2:385-389.
23. Rajagopalan P, Wudl F, Schinazi RF, Boudinot FD. Pharmacokinetics of a water-soluble fullerenes in rats. Antimicrob Agents Chemother 1996; 40:2262-2265.
24. 99mTc-C60(OH)x and its biodistribution studies. Nucl Med Biol 2002; 29:707-710.
25. Ueng TH, Kang JJ, Wang HW, Chen YW, Chiang LY. Suppression of microsomal cytochrome P450-dependent monooxygenases and mitochondrial oxidative phosphorylation by fullerenol a polyhydroxylated fullerene C60. Toxicol Lett 1997; 93:29-37.
26. Oberdorster E. Manufactured nanomaterials (fullerenes C60) induce oxidative stress in the brain of juvenile largemouth bass. Environ Health Perspect 2004; 112:1058-1062.
27. Friedman SH, DeCamp DL, Sijbesma RP, Srdanov G, Wudl F, Kenyon GL. Inhibition of the HIV-1 protease by fullerene derivatives: model building studies and experimental verification. J Am Chem Soc 1993; 115:6506-6509.
28. Monti D, Moretti L, Salvioli S, et al. C60 carboxyfullerene exerts a protective activity against oxidative stress-induced apoptosis in human peripheral blood mononuclear cells. Biochem Biophys Res Commun 2000; 277:711-717.
29. Tsuchiya T, Yamakoshi YN, Miyata N. A novel promoting action of fullerene C60 on the chondrogenesis in rat embryonic limb bud cell culture system. Biochem Biophys Res Commun 1995; 206:885-894.
30. Tsuchiya T, Oguri I, Yamakoshi YN, Miyata N. Novel harmful effects of [60]fullerene on mouse embryos in vitro and in vivo. Febs Lett 1996; 393:139-145.
31. Nelson MA, Frederick ED, Bowden GT, Hooser SB, Fernando Q, Carter DE. Effects of acute and subchronic exposure of topically applied fullerene extracts on the mouse skin. Toxicol Ind Health 1993; 9:623-630.
32. 14C-labeled C60 its suspension in water and its uptake by human keratinocytes. J Am Chem Soc 1994; 116:4517-4518.
33. Sayes CM, Fortner JD, Guo W, et al. The differential cytotoxicity of water-soluble fullerenes. Nano Lett 2004; 4:1881-1887.
34. Yang J, Barron AR. A new route to fullerene substituted phenylalanine derivatives. Chem Commun 2004:2884-2885.
35. Dai H, Hafner JH, Rinzler AG, Colbert DT, Smalley RE. Nanotubes as nanoprobes in scanning probe microscopy. Nature 1996; 384:147-150.
36. Moloni K, Lal A, Lagally MG. Sharpened carbon nanotube probes. Proc SPIE 2000; 4098:76-83.
37. Dagani R. Nanomaterials: safe or unsafe? Chem Eng News 2003; 81:30-33.
38. Warheit DB, Laurence BR, Reed KL, Roach DH, Reynolds GAM, Webb TR. Comparative pulmonary toxicity assessment of single wall carbon nanotubes in rats. Toxicol Sci 2004; 77:117-125.
39. Lam CW, James JT, McCluskey R, Hunter RL. Pulmonary toxicity of single wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci 2004; 77: 126-134.
40. Shvedova AA, Castranova V, Kisin ER, et al. Exposure to carbon nanotube materials: assessment of nanotube cytotoxicity using human keratinocytes cells. J Toxicol Environ Health A 2003; 66:1909-1926.
41. Allen DG, Riviere JE, Monteiro-Riviere NA. Cytokine induction as a measure of cutaneous toxicity in primary and immortalized porcine keratinocytes exposed to jet fuels and their relationship to normal human epidermal keratinocytes. Toxicol Lett 2001; 119:209-217.
42. Cunningham MJ, Magnuson SR, Falduto MT. Gene expression profiling of nanoscale materials using a systems biology approach. Toxicol Sci 2005; 84(S-1):9.
43. Kam NWS, Jessop TC, Wender PA, Dai H. Nanotube molecular transporters: internalization of carbon nanotube-protein conjugates into mammalian cells. J Am Chem Soc 2004; 126:6850-6851.
44. Pantarotto D, Briand JP, Prato M, Bianco A. Translocation of bioactive peptides across cell membranes by carbon nanotubes. Chem Commun 2004:16-17.
45. Gao H, Kong Y, Cui D, Ozkan CS. Spontaneous insertion of DNA oligonucleotides into carbon nanotubes. Nano Lett 2003; 3:471-473.
46. Cui D, Tian F, Ozkan CS, Wang M, Gao H. Effect of single wall carbon nanotubes on human HEK293 cells. Toxicol Lett 2005; 155:73-85.
47. Cherukuri P, Bachilo SM, Litovsky SH, Weisman RB. Near-infrared fluorescence microscopy of single-walled carbon nanotubes in phagocytic cells. J Am Chem Soc 2004; 126:15638-15639.
48. Monteiro-Riviere NA, Nemanich RA, Inman AO, Wang YY, Riviere JE. Multi-walled carbon nanotube interactions with human epidermal keratinocytes. Toxicol Lett 2005; 155:377-384.
49. Monteiro-Riviere NA. Multi-walled carbon nanotube exposure in human epidermal keratinocytes: localization and proteomic analysis. Proceedings of the 229th American Chemical Society Division of Industrial and Engineering Chemistry, 2005.
50. Monteiro-Riviere NA, Wang YY, Hong SM, et al. Proteomic analysis of nanoparticle exposure in human keratinocyte cell culture. Toxicologist 2005; 84(S-1):447.
51. Yokoyama A, Sato Y, Nodasaka Y, et al. Biological behavior of hat-stacked carbon nanofibers in the subcutaneous tissue in rats. Nano Lett 2005; 5:157-161.
52. Gupta AK, Curtis ASG. Surface modified superparamagnetic nanoparticles for drug delivery: interaction studies with human fibroblasts in culture. J Mater Sci: Mater Med 2004; 15:493-496.
53. Mecke A, Uppuluri S, Sassanella TM, et al. Direct observation of lipid bilayer disruption by poly(amidoamine) dendrimers. Chem Phys Lipids 2004; 132:3-14.
54. Hong S, Bielinska AU, Mecke A, et al. Interaction of poly(amidoamine) dendrimers with supported lipid bilayers and cells: hole formation and the relation to transport. Bioconjugate Chem 2004; 15:774-782.
55. Nigavekar SS, Sung LY, Llanes M, et al. 3H dendrimer nanoparticle organ/tumor distribution. Pharm Res 2004; 21:476-483.
56. Michalet X, Punaud FF, Bentolila LA, et al. Quantum dots for live cells in vivo imaging and diagnostics. Science 2005; 307:538-544.
57. Jovin TM. Quantum dots finally come of age. Nat Biotechnol 2003; 21:32-33.
58. Chan WCW, Nie S. Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science 1998; 281:2016-2018.
59. Larson DR, Zipfel WR, Williams RM, et al. Water-soluble quantum dots for multiphoton fluorescence imaging in vivo. Science 2003; 300:1434-1436.
60. Dubertret B, Skourides P, Norris DJ, Noireaux V, Brivanlou AH, Libchaber A. In vivo imaging of quantum dots encapsulated in phosopholipid micelles. Science 2002; 298:1759-1762.
61. Jaiswal JK, Mattoussi H, Mauro JM, Simon SM. Long-term multiple color imaging of live cells using quantum dot bioconjugates. Nat Biotechnol 2003; 21:47-51.
62. Derfus AM, Chan WCW, Bhatia S. Probing the cytotoxicity of semiconductor quantum dots. Nano Lett 2004; 4:11-18.
63. Shiosahara A, Hoshino A, Hanaki K, Suzuki K, Yamamoto K. On the cytotoxicity caused by quantum dots. Micobiol Immunol 2004; 48(9):669-675.
64. Lovric J, Bazzi H, Cuie Y, Fortin GRA, Winnik FM, Maysinger D. Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots. J Mol Med 2005 (published ahead of print).
65. Akerman ME, Chan WCW, Laakkonen P, Bhatia SN, Ruoslahti E. Nanocrystal targeting in vivo. Proc Natl Acad Sci 2002; 99(20):12617-12621.
66. Kim S, Lim YT, Soltesz EG, et al. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat Biotechnol 2004; 22(1):93-96.
67. Parak WJ, Boudreau R, Le Gros M, et al. Cell motility and metastatic potential studies based on quantum dot imaging of phagokinetic tracks. Adv Mater 2002; 14(12):882-885.
68. Bruchez M, Moronne M, Gin P, Weiss S, Alivisatos AP. Semiconductor nanocrystals as fluorescent biological labels. Science 1998; 281:2013-2016.
69. Green M, Howman E. Semiconductor quantum dots and free radical induced DNA nicking. Chem Commun 2005:121-123.
70. Baron PA, Maynard A, Foley M. Evaluation of aerosol release during the handling of unrefined single walled carbon nanotube material. Niosh Dart-02 2002:191.
71. Lansdown ABG, Taylor A. Zinc and titanium oxides: promising UV-absorbers but what influence do they have on intact skin. Int J Cosmet Sci 1997; 19:167-172.
72. Kwon GS. Diblock copolymer nanoparticles for drug delivery. Crit Rev Ther Drug Carrier Syst 1998; 15(5):481-512.
73. Monteiro-Riviere NA. Comparative anatomy physiology and biochemistry of mammalian skin. In: Hobson DW, ed. Dermal and Ocular Toxicology. Boca Raton: CRC Press, 1991:1-71.
74. Lecoanet HF, Bottero JY, Wiesner MR. Laboratory assessment of the mobility of nanomaterials in porous media. Environ Sci Technol 2004; 38:5164-5169.
75. Pickering KD, Wiesner MR. Fullerol-sensitive production of reactive oxygen species in aqueous solution. Environ Sci Technol 2005; 39:1359-1365.